Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-12-18: Form 6-K; Period of report 2025-12-18; Description 6-K; Document form6k_121825.htm.
- 2025-12-08: Form 6-K; Period of report 2025-12-08; Description 6-K; Document form6k_120825.htm.
- 2025-11-28: Form 6-K; Period of report 2025-11-28; Description 6-K; Document form6k_112825.htm.
- 2025-10-30: Form 6-K; Period of report 2025-10-30; Description 6-K; Document form6k-3_103025.htm.